4.63 USD
-0.01 (-0.22%)
Last: Jan 30, 2026, 08:02 PM
Overall LSTA gets a fundamental rating of 2 out of 10. We evaluated LSTA against 525 industry peers in the Biotechnology industry. LSTA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. LSTA does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
- LSTA had negative earnings in the past year.
- LSTA had a negative operating cash flow in the past year.
- LSTA had negative earnings in each of the past 5 years.
- LSTA had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- LSTA has a worse Return On Assets (-83.84%) than 69.71% of its industry peers.
- LSTA's Return On Equity of -105.00% is in line compared to the rest of the industry. LSTA outperforms 44.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -83.84% | ||
| ROE | -105% | ||
| ROIC | N/A |
ROA(3y)-56.5%
ROA(5y)-44.09%
ROE(3y)-64.1%
ROE(5y)-49.43%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for LSTA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- LSTA does not have a ROIC to compare to the WACC, probably because it is not profitable.
- LSTA has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for LSTA has been increased compared to 5 years ago.
- LSTA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- LSTA has an Altman-Z score of -32.60. This is a bad value and indicates that LSTA is not financially healthy and even has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of -32.60, LSTA is doing worse than 88.19% of the companies in the same industry.
- There is no outstanding debt for LSTA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -32.6 |
ROIC/WACCN/A
WACC8.88%
2.3 Liquidity
- A Current Ratio of 4.72 indicates that LSTA has no problem at all paying its short term obligations.
- Looking at the Current ratio, with a value of 4.72, LSTA is in line with its industry, outperforming 54.67% of the companies in the same industry.
- LSTA has a Quick Ratio of 4.72. This indicates that LSTA is financially healthy and has no problem in meeting its short term obligations.
- The Quick ratio of LSTA (4.72) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.72 | ||
| Quick Ratio | 4.72 |
3. Growth
3.1 Past
- LSTA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.14%, which is quite good.
EPS 1Y (TTM)15.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.95%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- LSTA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.18% yearly.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y9.05%
EPS Next 2Y26.17%
EPS Next 3Y19.8%
EPS Next 5Y12.18%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for LSTA. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LSTA. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as LSTA's earnings are expected to grow with 19.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.17%
EPS Next 3Y19.8%
5. Dividend
5.1 Amount
- No dividends for LSTA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
LISATA THERAPEUTICS INC / LSTA FAQ
What is the ChartMill fundamental rating of LISATA THERAPEUTICS INC (LSTA) stock?
ChartMill assigns a fundamental rating of 2 / 10 to LSTA.
What is the valuation status for LSTA stock?
ChartMill assigns a valuation rating of 0 / 10 to LISATA THERAPEUTICS INC (LSTA). This can be considered as Overvalued.
How profitable is LISATA THERAPEUTICS INC (LSTA) stock?
LISATA THERAPEUTICS INC (LSTA) has a profitability rating of 0 / 10.
How financially healthy is LISATA THERAPEUTICS INC?
The financial health rating of LISATA THERAPEUTICS INC (LSTA) is 6 / 10.
What is the earnings growth outlook for LISATA THERAPEUTICS INC?
The Earnings per Share (EPS) of LISATA THERAPEUTICS INC (LSTA) is expected to grow by 9.05% in the next year.